Biotechnology ResearchSeattle & Houston , United States11-50 Employees
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
| Indapta Therapeutics Email Formats | Percentage |
| FLast@indapta.com | 45% |
| First@indapta.com | 5% |
| FLast@indapta.com | 45% |
| First@indapta.com | 5% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| FLast@indapta.com | 45% |
| First@indapta.com | 5% |
| FLast@indapta.com | 45% |
| First@indapta.com | 5% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com